IRIS Institutional Research Information System - OPENBS Open Archive UniBS

NODARI, SAVINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.374
AS - Asia 21.378
EU - Europa 18.760
SA - Sud America 4.007
AF - Africa 416
OC - Oceania 83
Continente sconosciuto - Info sul continente non disponibili 35
AN - Antartide 2
Totale 75.055
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.728
CN - Cina 7.608
SG - Singapore 7.290
UA - Ucraina 5.281
IT - Italia 4.021
BR - Brasile 3.418
HK - Hong Kong 2.400
DE - Germania 2.226
FR - Francia 1.565
FI - Finlandia 1.261
IN - India 1.140
GB - Regno Unito 1.109
TR - Turchia 894
VN - Vietnam 857
PL - Polonia 828
IE - Irlanda 808
RU - Federazione Russa 733
CA - Canada 343
SE - Svezia 343
BD - Bangladesh 237
AR - Argentina 217
MX - Messico 200
IQ - Iraq 169
NL - Olanda 148
JP - Giappone 111
ZA - Sudafrica 102
ID - Indonesia 99
ES - Italia 93
PK - Pakistan 92
SA - Arabia Saudita 92
CO - Colombia 89
EC - Ecuador 84
AU - Australia 72
BE - Belgio 67
KE - Kenya 58
UZ - Uzbekistan 58
VE - Venezuela 51
NG - Nigeria 50
AT - Austria 48
MA - Marocco 46
PY - Paraguay 46
EG - Egitto 44
MU - Mauritius 41
MY - Malesia 40
CL - Cile 38
EU - Europa 31
TN - Tunisia 31
NO - Norvegia 29
CH - Svizzera 28
NP - Nepal 28
PE - Perù 25
AE - Emirati Arabi Uniti 24
UY - Uruguay 24
PH - Filippine 22
TW - Taiwan 22
JO - Giordania 20
CZ - Repubblica Ceca 19
JM - Giamaica 19
LT - Lituania 19
PT - Portogallo 19
BG - Bulgaria 18
KR - Corea 18
LB - Libano 17
IL - Israele 16
IR - Iran 16
RO - Romania 16
TT - Trinidad e Tobago 16
KZ - Kazakistan 15
OM - Oman 15
AZ - Azerbaigian 14
ET - Etiopia 14
TH - Thailandia 13
AL - Albania 12
CR - Costa Rica 12
DZ - Algeria 12
HU - Ungheria 12
BH - Bahrain 11
BO - Bolivia 11
HN - Honduras 11
NZ - Nuova Zelanda 11
PA - Panama 9
BA - Bosnia-Erzegovina 7
DO - Repubblica Dominicana 7
RS - Serbia 7
KG - Kirghizistan 6
KW - Kuwait 6
LK - Sri Lanka 6
LV - Lettonia 6
SK - Slovacchia (Repubblica Slovacca) 6
BB - Barbados 5
MD - Moldavia 5
NI - Nicaragua 5
SI - Slovenia 5
GR - Grecia 4
MK - Macedonia 4
PS - Palestinian Territory 4
SN - Senegal 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
AM - Armenia 3
Totale 74.992
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.833
Singapore 3.832
Hong Kong 2.383
Ashburn 2.105
Fairfield 1.972
Chandler 1.945
Woodbridge 1.700
Princeton 1.550
Nanjing 1.416
The Dalles 1.404
Beijing 1.391
Ann Arbor 1.244
Wilmington 1.217
Houston 1.203
San Jose 1.048
Cambridge 1.047
New York 879
Dublin 800
Warsaw 799
Seattle 719
Istanbul 686
Lauterbourg 682
Nanchang 534
Los Angeles 511
Helsinki 468
Milan 448
Buffalo 392
Des Moines 383
Hebei 341
Shenyang 324
São Paulo 310
Ho Chi Minh City 308
Moscow 304
Changsha 258
Rome 248
Tianjin 236
Jiaxing 230
San Diego 185
Kunming 180
Hanoi 169
Dearborn 165
Verona 154
Redondo Beach 151
Jinan 149
Brescia 134
Hangzhou 134
Orem 134
San Francisco 130
Kocaeli 114
Shanghai 112
Rio de Janeiro 109
Dallas 107
Newton 99
Toronto 95
Mexico City 93
Boardman 89
Chicago 86
Tokyo 83
Munich 81
Council Bluffs 77
Guangzhou 76
Santa Clara 76
Zhengzhou 76
Chennai 75
London 71
Belo Horizonte 69
Brooklyn 69
Lancaster 69
Naples 67
Florence 62
Ningbo 61
Frankfurt am Main 60
Vancouver 58
Lanzhou 55
Manchester 55
Baghdad 54
Brasília 52
Norwalk 52
Tashkent 52
Bologna 51
Changchun 51
Nairobi 50
Taizhou 49
Abuja 48
Denver 48
Atlanta 47
Brussels 47
Curitiba 46
Porto Alegre 46
Palermo 43
Salvador 42
Johannesburg 41
Nuremberg 41
Pune 41
Boston 40
Guarulhos 40
Montreal 40
Riyadh 40
Catania 38
Dhaka 38
Totale 44.116
Salva come PNG Salva come JPEG
Nome #
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction 1.056
Un caso di Sindrome di Bland-White-Garland: origine anomala dell’arteria coronaria sinistra dall’arteria polmonare. 725
Inodilatatori: perché e quali. 405
Livelli circolanti del marcatore tumorale CA 125 in pazienti con scompenso cardiaco cronico:relazione con la classe NYHA, i parametri ecocardiografici e variazioni indotte dalla terapia. 360
Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial) 342
Il genotipo DD per il gene dell’enzima di conversione dell’angiotensina identifica i pazienti con insufficienza cardiaca che possono beneficiare di dosi medio elevate di ACE inibitori. 339
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 333
Valutazione dell’indice di performance miocardica (MPI) del ventricolo destro con studio eco-doppler in pazienti affetti da insufficienza cardiaca. 321
I polimorfismi Arg16Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca 255
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 255
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study 253
L’ indice di performance miocardica ( MPI ) è un importante indicatore prognostico nei pazienti affetti da insufficienza cardiaca cronica. 236
I polimorfismi Arg16 Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca. 232
Effects of supplementation with polyunsaturated fatty acids in patients with heart failure. 221
Risk of Cardiovascular Hospitalizations from Exposure to Coarse Particulate Matter (PM10) Below the European Union Safety Threshold 211
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 208
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. 207
A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension. 192
Efficacia di un nuovo diuretico, la muzolimina, in pazienti con insufficienza cardiaca. 191
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 191
Valvola aortica quadricuspide asintomatica : un caso clinico. 190
The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. 190
Determinazione dell’equilibrio simpato-vagale attraverso l’analisi spettrale della variabilità della frequenza cardiaca in pazienti con insufficienza cardiaca di diverso grado di severità. 189
Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: Findings from the ASTRONAUT trial 188
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 179
Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review 175
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 170
A rationale for the use of BETA-blockers as standard treatment for heart failure 170
Clinical trials update from the World Congress of Cardiology 2006. 168
Are Beta-1 and alpha2c-adrenergic receptor polymorphisms associated with an increased risk of heart failure in Caucasian subjects: results of a case-control study 168
Beta- adrenergic receptors polymorphisms and response to CRT 166
Serum levels of different tumoral markers in patients with congestive heart failure. 164
Acute heart failure syndromes: assessment and reconstructing the heart. 162
Combination decongestion therapy in hospitalized heart failure: loop diuretics, mineralocorticoid receptor antagonists and vasopressin antagonists 161
Anemia and heart failure : a cause of progression or only a consequence? 158
Prognostic Value of Serial Clinical, Laboratory and Ecocardiographic Tests in Ambulatory Patients with Chronic Heart Failure 158
1Beta-2 adrenergic receptors gene polymorphisms influence the effects of carvedilol in the patients with heart failure. 157
The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T 157
Raised homocystein plasma concentration in patients with heart failure: Clinical significance 157
Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial) 155
Effects of aldosterone blockers on left ventricular function and remodeling in patients with mild-moderate chronic heart failure. 154
Clinical significance of Beta-adrenergic receptor polymorphisms in the patients with chronic heart failure 153
Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients with Chronic Heart Failure 153
Angiotensin-converting-enzyme gene polymorphism and heart failure: a case-control study. 151
A randomized double blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant hypertension. Ca+ Nicardipine. Selected reports from the worldwide literature. 149
Usefulness of cardiac calcification on two-dimensional echocardiography for distinguishing ischaemic from nonischaemic dilated cardiomyopathy: a preliminary report. 148
Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial 147
Acute antianginal efficacy and duration of action of isosorbide 2-mononitrate. 146
Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial 146
A randomized comparison of the effects of metoprolol and carvedilol on the hemodynamics and functional capacity of patients with heart failure. 145
Cardiovascular and non cardiovascular comorbidities in patients with chronic heart failure. 144
The 6-min walking test early after cardiac surgery. Reference values and the effects of rehabilitation programme. 142
Nutritional Supplementation with Amino Acids in Ambulatory Patients with Idiophatic Dilatated Cardiomyophaty 142
A new dopamine derivative, ibopamine, in the chronic treatment of heart failure: one year follow-up. 141
Significato prognostico indipendente della frequenza cardiaca a riposo alla dimissione come predittore di mortalità in pazienti ricoverati per insufficienza cardiaca acuta. 141
Asse cuore-rene nell’iperteso cardiopatico. 140
Acute and chronic effects of nisoldipine in patients with chronic heart failure. 140
n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. 139
Influence of the angiotensin-converting enzyme genotype on the response to the beta-blocker therapy and the prognosis of the patients with chronic heart failure. 138
A Current treatment in acute and chronic cardio-renal syndrome. 137
Effects of oral amino Acid supplements on functional capacity in patients with chronic heart failure. 136
[Chronic heart failure therapy: where we are and where we are going to] 136
Acute hemodynamic and neurohumoral effects of the oral dopamine derivative ibopamine in patients with heart failure. 135
Independent role of resting heart rate at discharge as a predictor of mortality after hospitalisation for acute heart failure. 134
Effects of Polyunsaturated Fatty Acid Treatment on Postdischarge Outcomes After Acute Myocardial Infarction 134
Six-year prognosis of diabetic patients with coronary artery disease. 133
Valore prognostico delle variazioni dell'indice di distribuzione dei volumi eritrocitari (RDW) nello scompenso cardiaco cronico. 133
Response to the letter of Hester Den Ruijter and Ruben Coronel regarding the article "the role of n-3 pufas in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy" 133
Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial) 133
Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion 133
Preventing antiblastic drug-related cardiomyopathy: old and new therapeutic strategies 133
Ruolo prognostico della fibrinogemia in pazienti diabetici ricoverati per sindrome coronarica acuta. 130
Lack of association of coeliac disease with idiopathic and ischaemic dilated cardiomyopathies. 130
Improved graft patency rates and mid-term outcome of diabetic patients undergoing total arterial myocardial revascularization. 130
Mediterranean diet impact on cardiovascular diseases: A narrative review 130
Ibopamine treatment in dopamine dependent heart failure: purpose of a new treatment scheme. 128
Rest and exercise effects of the acute and chronic administration of nisoldipine in patients with heart failure. 128
Different prognostic values of clinical and metabolic parameters in ischaemic diabetic patients with preserved/impaired left ventricular function. 128
Prognostic value of serial measurements of blood urea nitrogen in ambulatory patients with chronic heart failure 128
Beta-1 adrenoceptor gene polimorphism in heart failure: clinical and prognostic significance in female patients. 127
Redefining biomarkers in heart failure 127
Valutazione emodinamica e neurormonale di tre agenti dopaminergici in pazienti con grave insufficienza cardiaca. 126
Predicting heart failure outcome from cardiac and comorbid conditions: the 3C-HF score 126
Weight loss favorably affects the cardiac sympatho-vagal balance of the obese patients: results of power spectral analysis of heart rate variability. 125
Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. 125
A new educational program in heart failure drug development: The Brescia international master program 125
Bilancia simpatovagale ed eziologia dell’insufficienza cardiaca: valutazione mediante analisi spettrale della variabilità della frequenza cardiaca. 124
C – Reactive protein and chronic chlamydia pneumoniae infection in patients with acute ischemic syndromes 124
Role of fluid retention in patients hospitalised for acute heart failure. 124
Beta-1 adrenergic receptor gene polimorphism in heart failure: a gender specific clinical and prognostic role? 124
Usefulness of cardiac calcification on two-dimensional echocardiography for distinguishing ischaemic from nonischaemic dilated cardiomyopathy: a preliminary report 123
Effects of Spironolactone on Long-term Mortality and Morbidity in Patients With Heart Failure and Mild or No Symptoms. 123
Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions 123
Maximal and submaximal exercise testing in heart failure. 123
Le calcificazioni intracardiache all’esame ecocardiografico nella diagnosi differenziale tra cardiomiopatia dilatativa ischemica ed idiopatica. 122
Analisi costo-efficacia della stimolazione biventricolare: risultati dello studio Brescia 122
Abnormal hemodynamics and ventilatory response to exercise may identify chronic heart failure patients at high risk despite long term beta-blocker treatment. 121
Danno cardiaco in pazienti con patologia encefalica acuta ricoverati in terapia intensiva: possibili meccanismi fisiopatologici. 121
Is total arterial myocardial revascularization with composite grafts a safe and useful procedure in the elderly? 121
Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial 121
Totale 17.913
Salva come PNG Salva come JPEG
Categoria #
all - tutte 359.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 359.738
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.596 0 0 0 0 0 0 0 0 0 521 921 154
2021/20225.011 136 1.082 50 343 85 253 151 371 292 647 523 1.078
2022/20235.509 852 63 48 516 513 1.620 16 565 855 44 194 223
2023/20244.104 333 101 174 234 145 740 121 110 1.207 60 99 780
2024/202510.958 65 57 93 1.249 1.485 762 930 452 1.169 568 2.476 1.652
2025/202619.533 1.917 3.326 1.497 2.917 1.674 1.304 3.230 922 1.276 1.470 0 0
Totale 75.592